Dexketoprofen trometamol

CAS No. 156604-79-4

Dexketoprofen trometamol( —— )

Catalog No. M23677 CAS No. 156604-79-4

Dexketoprofen trometamol is a modified non-selective COX inhibitor with a rapid onset of action that is available as both oral and parenteral formulations.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 51 In Stock
10MG 74 In Stock
25MG 135 In Stock
50MG 192 In Stock
100MG 275 In Stock
200MG 394 In Stock
500MG 591 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Dexketoprofen trometamol
  • Note
    Research use only, not for human use.
  • Brief Description
    Dexketoprofen trometamol is a modified non-selective COX inhibitor with a rapid onset of action that is available as both oral and parenteral formulations.
  • Description
    Dexketoprofen trometamol is a modified non-selective COX inhibitor with a rapid onset of action that is available as both oral and parenteral formulations.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Chromatin/Epigenetic
  • Target
    COX
  • Recptor
    COX-2
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    156604-79-4
  • Formula Weight
    375.42
  • Molecular Formula
    C20H25NO6
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (266.37 mM)
  • SMILES
    O=C(C1=CC=CC([C@H](C)C(O)=O)=C1)C2=CC=CC=C2.OCC(CO)(CO)N
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Hanna M , Moon J Y . A review of dexketoprofen trometamol in acute pain[J]. Current Medical Research and Opinion, 2018:1-32.
molnova catalog
related products
  • Hydroxytoluic acid

    The salts or esters of salicylic acids, or salicylate esters of an organic acid.

  • Feladilimab

    Feladilimab (GSK3359609) is an IgG4 monoclonal antibody that is an ICOS agonist.

  • Sulindac

    Sulindac is a nonsteroidal anti-inflammatory agent (NSAIA) of the arylalkanoic acid class that is marketed in the U.S. by Merck as Clinoril.